Yıl: 2015 Cilt: 6 Sayı: 5 Sayfa Aralığı: 581 - 585 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Premenstrual Symptom Screening Tool: A Useful Tool for DSM-5 Premenstrual Dysphoric Disorder

Öz:
Amaç: Aybaşı Öncesi Belirtileri Tarama Gereci'nin (AÖBTG) Türkiye'deki bir örneklemde Aybaşı Öncesi Disfori Sendromu (AÖDS) ve orta şiddetli Aybaşı Öncesi Sendromunu (AÖS) tespit etmede kullanışlılığını değerlendirmektir. Gereç ve Yöntem: Dışkapı YB Eğitim ve Araştırma Hastanesinde farklı birimlerde çalışan ve halen adet görmeye devam eden 118 kadın çalışmaya alınmıştır. Katılımcılara sosyodemografik veri formu AÖBTG, Belirti Kontrol Listesi (SCL-90-R) doldurtulmuştur. Katılımcılar, AÖBTG'de yaptıkları işaretlemelere göre AÖDS, AÖS ve Eşik Altı AÖS belirtileri olan grup olarak üç gruba ayrılmıştır. Bu gruplar gereç puanları ve SCL-90-R'ye verdikleri yanıtlar açısından karşılaştırılmıştır. Bulgular: Gereç maddelerinin iç tutarlılığı çok iyi düzeydeydi (Cronbach ?=0.928). Bu örneklemde AÖDS ve AÖS'nin yaygınlığı sırasıyla %15,2 (n=18) ve %32,2 (n=38) olarak bulundu. SCL-90-R Alt-testlerinden alından puanlar karşılaştırıldığında AÖDS veya AÖS ile eşik altı belirtileri olan gruplar arasında anlamlı fark vardı. Ayrıca AÖBTG maddelerini orta veya şiddetli olarak işaretleyen katılımcı oranları karşılaştırıldığında her üç grup da AÖDS tanısı için gerekli olan ilk dört maddede farklılık gösterdi. Tartışma: Aybaşı Öncesi Belirtileri Tarama Gereci AÖDS tanısı almaya aday olan ve halen orta ila şiddetli AÖS yaşayan kadınları tespit etmede kullanışlı bir araçtır.
Anahtar Kelime:

Konular: Genel ve Dahili Tıp

Aybaşı Öncesi Belirtileri Tarama Gereci: DSM-5 Aybaşı Öncesi Disfori Bozukluğunu Taramada Kullanışlı bir Gereç ,

Öz:
Aim: To assess the usefulness of Premenstrual Symptoms Screening Tool (PSST) in detecting Premenstrual Dysphoric Syndrome (PMDD) and Premenstrual Syndrome (PMS) in a Turkish sample. Material and Method: One hundred and eighteen women were included in the study. Participants were menstruating women, between the ages of 18 and 49 years who work in various departments of Diskapi Yildirim Beyazit Teaching and Research Hospital. Sociodemographic data collection form, PSST, and Symptom Check List (SCL90-R) were given to the participants, filled out by participants and checked out by researchers. Participants were divided into three groups (i.e., women with subthreshold premenstrual symptoms, women with PMDD, and women with PMS) according to the scores they get on the PSST. These groups were compared according to PSST scores and SCL-90-R scores. Results: Internal consistency was excellent (Cronbach ?=0.928) for the items of the tool. In this sample, the prevalence of the PMDD and PMS were 15.2 % (n=18) and 32.2 % (n=38) respectively. When we compare the scores on SCL-90-R subscales there were significant differences between the PMDD, PMS, and women with subthreshold groups. Besides there were significant differences for the three groups in terms of percentages of women who reported moderate to severe symptoms on the four items that are essential to PMDD diagnosis. Discussion: Premenstrual Symptoms Screening Tool is a useful tool to detect candidates for PMDD and moderate to severe PMS.
Anahtar Kelime:

Konular: Genel ve Dahili Tıp
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Mason-Hohl E. The diseases of women, by trotula of salerno: A Translation of Passionibus Mulierum Curandorum by Elizabeth Mason-Hohl, MD. Los Angeles, Ward Ritchie Press; 1940.
  • 2. Greene R, Dalton K. The premenstrual syndrome. Br Med J 1953;1(4818):1007– 14.
  • 3. Teng CT, Vieira Filho AH G, Artes R., Gorenstein C, Andrade LH, Wang YP. Premenstrual dysphoric symptoms amongst Brazilian college students: factor structure and methodological appraisal. Eur Arch Psychiatry Clin Neurosci 2005;255(1):51-6.
  • 4. World Health Organization. The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. World Health Organization; New- York; 1993.
  • 5. Steiner M, Macdougall M, Brown E. The premenstrual symptoms screening tool (PSST) for clinicians. Arch Womens Ment Health 2003;6(3):203–9.
  • 6. Türkçapar AF, Türkçapar MH. Premenstruel sendrom ve premenstruel disforik bozuklukta tani ve tedavi: Bir gözden geçirme. Klinik Psikiyatri 2011;14(4):241-53.
  • 7. Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006;63(4):375.
  • 8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed, revised (DSM-III-R). Washington, DC, American Psychiatric Association, Inc; 1987.
  • 9. Amerikan Psikiyatri Birliği (1994) Mental Bozuklukların Tanısal ve Sayımsal El Kitabı, Dördüncü Baskı (DSM-IV) (Çev. ed.: E Köroğlu) Hekimler Yayın Birliği, Ankara; 1995.
  • 10. Epperson CN, Steiner M, Hartlage SA, Eriksson E, Schmidt PJ, Jones I, Yonkers KA. Premenstrual dysphoric disorder: evidence for a new category for DSM-5. Am J Psychiatry 2012;169(5):465-75.
  • 11. Gehlert S, Song IH, Chang CH, Hartlage SA. The prevalence of premenstrual dysphoric disorder in a randomly selected group of urban and rural women. Psychol Med 2009;39(1):129–36.
  • 12. Hurt SW, Schnurr PP, Severino SK, Freeman EW, Gise LH, Rivera- Tovar A et al. Late luteal phase dysphoric disorder in 670 women evaluated for premenstrual complaints. Am J Psychiatry 1992;149(4):525-30.
  • 13. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing, Inc; 2013.
  • 14. Steiner M. Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management. J Psychiatry Neurosci 2000;25(5):459.
  • 15. Halbreich U, Borenstein J, Pearlstein T, Kahn LS. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS). Psychoneuroendocrinology 2003;28(Suppl.3):1-23.
  • 16. Bhatia SC, Bhatia SK. Diagnosis and treatment of premenstrual dysphoric disorder. Am Fam Physician 2002;66(7):1239-49.
  • 17. Müderris II, Gönül AS, Sofuoğlu S, Taşcı S, Bayatlı M. Genç kadınlarda premenstrüel disforik bozukluk prevalansı. Klinik Psikiyatri 1999;2(3):197-201.
  • 18. Mortola JF, Girton L, Beck L, Yen SSC. Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: the calendar of premenstrual experiences. Obstet Gynecol 1990;76(2):302-7.
  • 19. Steiner M, Peer M, Palova E, Freeman EW, Macdougall M, Soares CN. The Premenstrual Symptoms Screening Tool revised for adolescents (PSST-A): prevalence of severe PMS and premenstrual dysphoric disorder in adolescents. Arch Womens Ment Health 2011;14(1):77-81.
  • 20. Buttner MM, Mott SL, Pearlstein T, Stuart S, Zlotnick C, O’Hara MW. Examination of premenstrual symptoms as a risk factor for depression in postpartum women. Arch Womens Ment Health 2013;16(3):219-25.
  • 21. Derogatis LR, Kazdin AE. SCL-90-R. In A. E. Kadin (Ed.), Encyclopedia of psychology, Vol. 7. American Psychological Association; 2000. p.192-3.
  • 22. Dağ I. Belirti Tarama Listesi (Scl-90-R)’nin Üniversite Öğrencileri için güvenirliği ve geçerliği. / Reliability and validity of the Symptom Check List (SCL-90-R) for university students. Turk Psikiyatri Derg 1991;2(1):5–12.
  • 23.Wittchen HU, Becker E, Lieb R., Krause P. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychological Medicine 2002;32(1):119-32.
  • 24. Adiguzel H, Taskin EO, Danaci AE. The symptomatology and prevalence of symptoms of premenstrual syndrome in Manisa, Turkey. Turk Psikiyatri Derg 2007;18(3):215-22.
  • 25. Rivera-Tovar A, Pilkonis P, Frank E. Symptom patterns in late luteal-phase dysphoric disorder. J Psychopathol Behav Assess 1992;14(2):189–99.
  • 26. Meaden PM, Hartlage SA, Cook-Karr J. Timing and severity of symptoms associated with the menstrual cycle in a community-based sample in the Midwestern United States. Psychiatry Res 2005;134(1):27–36.
  • 27. Hartlage SA, Freels A, Gotman N, Yonkers KA. Criteria for premenstrual dysphoric disorder: secondary analyses of relevant data sets. Arch Gen Psychiatry 2012;69(3):300–5.
  • 28. Treloar SE, Heath AC, Martin NG. Genetic and environmental influences on premenstrual symptoms in an Australian twin sample. Psychol Med 2002;32(1):25–38.
APA özdel k, KERVANCIOĞLU A, taymur i, EFE C, TÜRKÇAPAR A, GÜRİZ S, Turkcapar M (2015). Premenstrual Symptom Screening Tool: A Useful Tool for DSM-5 Premenstrual Dysphoric Disorder. , 581 - 585.
Chicago özdel kadir,KERVANCIOĞLU Ayşegül,taymur ibrahim,EFE Canan,TÜRKÇAPAR Ayşe Figen,GÜRİZ Seher Olga,Turkcapar Mehmet Hakan Premenstrual Symptom Screening Tool: A Useful Tool for DSM-5 Premenstrual Dysphoric Disorder. (2015): 581 - 585.
MLA özdel kadir,KERVANCIOĞLU Ayşegül,taymur ibrahim,EFE Canan,TÜRKÇAPAR Ayşe Figen,GÜRİZ Seher Olga,Turkcapar Mehmet Hakan Premenstrual Symptom Screening Tool: A Useful Tool for DSM-5 Premenstrual Dysphoric Disorder. , 2015, ss.581 - 585.
AMA özdel k,KERVANCIOĞLU A,taymur i,EFE C,TÜRKÇAPAR A,GÜRİZ S,Turkcapar M Premenstrual Symptom Screening Tool: A Useful Tool for DSM-5 Premenstrual Dysphoric Disorder. . 2015; 581 - 585.
Vancouver özdel k,KERVANCIOĞLU A,taymur i,EFE C,TÜRKÇAPAR A,GÜRİZ S,Turkcapar M Premenstrual Symptom Screening Tool: A Useful Tool for DSM-5 Premenstrual Dysphoric Disorder. . 2015; 581 - 585.
IEEE özdel k,KERVANCIOĞLU A,taymur i,EFE C,TÜRKÇAPAR A,GÜRİZ S,Turkcapar M "Premenstrual Symptom Screening Tool: A Useful Tool for DSM-5 Premenstrual Dysphoric Disorder." , ss.581 - 585, 2015.
ISNAD özdel, kadir vd. "Premenstrual Symptom Screening Tool: A Useful Tool for DSM-5 Premenstrual Dysphoric Disorder". (2015), 581-585.
APA özdel k, KERVANCIOĞLU A, taymur i, EFE C, TÜRKÇAPAR A, GÜRİZ S, Turkcapar M (2015). Premenstrual Symptom Screening Tool: A Useful Tool for DSM-5 Premenstrual Dysphoric Disorder. Journal of Clinical and Analytical Medicine, 6(5), 581 - 585.
Chicago özdel kadir,KERVANCIOĞLU Ayşegül,taymur ibrahim,EFE Canan,TÜRKÇAPAR Ayşe Figen,GÜRİZ Seher Olga,Turkcapar Mehmet Hakan Premenstrual Symptom Screening Tool: A Useful Tool for DSM-5 Premenstrual Dysphoric Disorder. Journal of Clinical and Analytical Medicine 6, no.5 (2015): 581 - 585.
MLA özdel kadir,KERVANCIOĞLU Ayşegül,taymur ibrahim,EFE Canan,TÜRKÇAPAR Ayşe Figen,GÜRİZ Seher Olga,Turkcapar Mehmet Hakan Premenstrual Symptom Screening Tool: A Useful Tool for DSM-5 Premenstrual Dysphoric Disorder. Journal of Clinical and Analytical Medicine, vol.6, no.5, 2015, ss.581 - 585.
AMA özdel k,KERVANCIOĞLU A,taymur i,EFE C,TÜRKÇAPAR A,GÜRİZ S,Turkcapar M Premenstrual Symptom Screening Tool: A Useful Tool for DSM-5 Premenstrual Dysphoric Disorder. Journal of Clinical and Analytical Medicine. 2015; 6(5): 581 - 585.
Vancouver özdel k,KERVANCIOĞLU A,taymur i,EFE C,TÜRKÇAPAR A,GÜRİZ S,Turkcapar M Premenstrual Symptom Screening Tool: A Useful Tool for DSM-5 Premenstrual Dysphoric Disorder. Journal of Clinical and Analytical Medicine. 2015; 6(5): 581 - 585.
IEEE özdel k,KERVANCIOĞLU A,taymur i,EFE C,TÜRKÇAPAR A,GÜRİZ S,Turkcapar M "Premenstrual Symptom Screening Tool: A Useful Tool for DSM-5 Premenstrual Dysphoric Disorder." Journal of Clinical and Analytical Medicine, 6, ss.581 - 585, 2015.
ISNAD özdel, kadir vd. "Premenstrual Symptom Screening Tool: A Useful Tool for DSM-5 Premenstrual Dysphoric Disorder". Journal of Clinical and Analytical Medicine 6/5 (2015), 581-585.